You are here
- Disease
- solid tumour
- Drug Name
- Caprelsa
- Generic Name
- vandetanib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- II
- Start Date
- Oct 1, 2002
- Study Name
- 6474IL/0006
- Study Id
- 6474IL/0006
- ClinicalTrials.gov ID
- NCT00047840
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
